Published in Expert Opin Drug Metab Toxicol on October 01, 2009
Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol (2012) 1.46
The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic cultures. Biomaterials (2010) 1.37
In vitro models for liver toxicity testing. Toxicol Res (Camb) (2012) 1.13
Bioreactor technologies to support liver function in vitro. Adv Drug Deliv Rev (2014) 1.05
Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clin Exp Metastasis (2011) 1.01
Engineering liver. Hepatology (2014) 0.95
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. Am J Physiol Cell Physiol (2013) 0.92
A microphysiological system model of therapy for liver micrometastases. Exp Biol Med (Maywood) (2014) 0.89
A novel low-volume two-chamber microfabricated platform for evaluating drug metabolism and toxicity. Technology (Singap World Sci) (2015) 0.85
A novel 3D liver organoid system for elucidation of hepatic glucose metabolism. Biotechnol Bioeng (2011) 0.84
Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor. Drug Metab Dispos (2015) 0.84
All-human microphysical model of metastasis therapy. Stem Cell Res Ther (2013) 0.83
Photopatterning of hydrogel scaffolds coupled to filter materials using stereolithography for perfused 3D culture of hepatocytes. Biotechnol Bioeng (2015) 0.82
Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. Technology (Singap World Sci) (2015) 0.81
The multi-organ chip--a microfluidic platform for long-term multi-tissue coculture. J Vis Exp (2015) 0.80
Cell patterning for liver tissue engineering via dielectrophoretic mechanisms. Sensors (Basel) (2014) 0.78
Addressing the challenges of low clearance in drug research. AAPS J (2015) 0.78
Modeling Therapeutic Antibody-Small Molecule Drug-Drug Interactions Using a Three-Dimensional Perfusable Human Liver Coculture Platform. Drug Metab Dispos (2016) 0.77
Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response. Sci Rep (2016) 0.76
3D Cultivation Techniques for Primary Human Hepatocytes. Microarrays (Basel) (2015) 0.75
Recapitulation of metabolic defects in a model of propionic acidemia using patient-derived primary hepatocytes. Mol Genet Metab (2015) 0.75
Acetaminophen induces accumulation of functional rat CYP3A via polyubiquitination dysfunction. Sci Rep (2016) 0.75
Liver Cell Culture Devices. Cell Med (2010) 0.75
Quantitative Assessment of Population Variability in Hepatic Drug Metabolism Using a Perfused Three-Dimensional Human Liver Microphysiological System. J Pharmacol Exp Ther (2016) 0.75
Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX (2016) 0.75
Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. World J Gastroenterol (2017) 0.75
Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization. Sci Rep (2017) 0.75
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol (2005) 13.90
Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol (2006) 8.81
Drug-induced hepatotoxicity. N Engl J Med (2003) 7.11
Liver regeneration. J Hepatol (2000) 5.22
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation (2002) 4.64
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J (1999) 4.22
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog (1991) 3.21
Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sci U S A (1994) 3.09
A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). J Biomed Mater Res (1993) 2.67
Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology (1994) 2.37
A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol (1995) 2.33
Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. Proc Natl Acad Sci U S A (1988) 2.30
Role of stroma in carcinogenesis of the prostate. Differentiation (2002) 2.26
Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol (2006) 2.21
Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology (1995) 2.17
High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol (2006) 2.12
Three-dimensional cellular microarray for high-throughput toxicology assays. Proc Natl Acad Sci U S A (2007) 2.09
Hedgehog signaling maintains resident hepatic progenitors throughout life. Am J Physiol Gastrointest Liver Physiol (2005) 2.02
Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol Ther (1992) 2.02
Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest (1995) 1.89
Perfused multiwell plate for 3D liver tissue engineering. Lab Chip (2009) 1.88
Functional hepatocellular heterogeneity. Hepatology (1982) 1.88
A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng (2002) 1.87
Convergence of Wnt signaling on the HNF4alpha-driven transcription in controlling liver zonation. Gastroenterology (2009) 1.85
An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol Bioeng (2007) 1.75
The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J Clin Gastroenterol (2005) 1.72
Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation (2003) 1.70
Computer-controlled microcirculatory support system for endothelial cell culture and shearing. Anal Chem (2005) 1.70
Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng (2007) 1.68
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. J Pharmacol Exp Ther (2004) 1.67
Mechanisms of drug-induced liver injury. AAPS J (2006) 1.65
Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J (2002) 1.65
Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng (2001) 1.64
The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity. Am J Physiol Gastrointest Liver Physiol (2007) 1.61
A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab (2005) 1.61
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci (2001) 1.59
Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities. Lab Chip (2004) 1.53
Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci (2008) 1.49
Drug-induced liver injury: mechanisms and test systems. Hepatology (2001) 1.49
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. Toxicol Appl Pharmacol (2009) 1.49
A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip (2009) 1.49
Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials (2005) 1.48
Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation (2002) 1.47
Formation of extensive canalicular networks by rat hepatocytes cultured in collagen-sandwich configuration. Am J Physiol (1994) 1.46
Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. Toxicol Sci (2007) 1.45
Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration. Am J Physiol (1999) 1.45
Liver cell models in in vitro toxicology. Environ Health Perspect (1998) 1.42
Differential gene expression in periportal and perivenous mouse hepatocytes. FEBS J (2006) 1.41
The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol Appl Pharmacol (1993) 1.38
Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes. FASEB J (2007) 1.35
Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica (2002) 1.33
Hard top soft bottom microfluidic devices for cell culture and chemical analysis. Anal Chem (2009) 1.32
Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions. Biotechnol Bioeng (2004) 1.30
Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol (2007) 1.29
Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica (2000) 1.28
Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology (1992) 1.27
Use and application of stem cells in toxicology. Toxicol Sci (2004) 1.26
Visualizing muscle cell migration in situ. Curr Biol (2000) 1.22
Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr Drug Metab (2004) 1.22
A hemodynamic response to intravenous adenovirus vector particles is caused by systemic Kupffer cell-mediated activation of endothelial cells. Hum Gene Ther (2003) 1.22
Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther (2008) 1.21
Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol (2009) 1.21
The role of non-parenchymal cells in liver growth. Semin Cell Dev Biol (2002) 1.20
Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro. Am J Pathol (1993) 1.20
Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix. J Cell Physiol (1998) 1.20
Time course of primary liver cell reorganization in three-dimensional high-density bioreactors for extracorporeal liver support: an immunohistochemical and ultrastructural study. Tissue Eng (2004) 1.18
Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats. J Pharmacol Exp Ther (2003) 1.17
Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor. Tissue Eng (2002) 1.16
Order and disorder: the role of extracellular matrix in epithelial cancer. Cancer Invest (2002) 1.15
Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology (1999) 1.14
Liver tissue engineering: a role for co-culture systems in modifying hepatocyte function and viability. Tissue Eng (2001) 1.14
Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology (2000) 1.14
Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses. Proc Natl Acad Sci U S A (2005) 1.13
Long-term primary cultures of adult human hepatocytes. Chem Biol Interact (1997) 1.13
Two-dimensional multiarray formation of hepatocyte spheroids on a microfabricated PEG-brush surface. Chembiochem (2004) 1.12
Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur J Biochem (1992) 1.12
Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. Toxicol Sci (2005) 1.09
Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol Bioeng (2002) 1.08
Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation. J Pharmacol Exp Ther (2006) 1.07
Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: a mechanism of negative regulation of hepatocyte proliferation. Hepatology (1997) 1.06
Long-term maintenance of hepatocyte functional activity in co-culture: requirements for sinusoidal endothelial cells and dexamethasone. J Cell Physiol (1986) 1.06
Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm Res (2004) 1.05
Hepatocyte-supported serum-free culture of rat liver sinusoidal endothelial cells. J Hepatol (2000) 1.04
Characterization and functional studies on rat liver fat-storing cell line and freshly isolated hepatocyte coculture system. Am J Pathol (1995) 1.04
New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab Rev (2003) 1.04
Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Chem Biol Interact (2004) 1.03
Mass transfer and metabolic reactions in hepatocyte spheroids cultured in rotating wall gas-permeable membrane system. Biomaterials (2007) 1.03
Direct cell-to-cell contact between Kupffer cells and hepatocytes augments endotoxin-induced hepatic injury. Am J Physiol Gastrointest Liver Physiol (2001) 1.03
O2 uptake in periportal and pericentral regions of liver lobule in perfused liver. Am J Physiol (1986) 1.03
Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Drug Metab Dispos (2006) 1.02
Long-term culture of functional liver tissue: three-dimensional coculture of primary hepatocytes and stellate cells. Tissue Eng (2003) 1.02
Hepatocyte and kupffer cells co-cultured on micropatterned surfaces to optimize hepatocyte function. Tissue Eng (2006) 1.02
Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes. Eur J Pharmacol (1999) 1.01
Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance. Acta Biomater (2005) 1.01
Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture. Toxicol Sci (2007) 1.00
Long-term culture of adult rat hepatocyte spheroids. Exp Cell Res (1992) 1.00
The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos (2003) 3.33
Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am (2004) 2.79
A patterned anisotropic nanofluidic sieving structure for continuous-flow separation of DNA and proteins. Nat Nanotechnol (2007) 2.66
Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J Cell Sci (2002) 2.42
Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys (2004) 2.24
Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells (2007) 2.03
Microfluidic shear devices for quantitative analysis of cell adhesion. Anal Chem (2004) 1.95
The hydantoin lesions formed from oxidation of 7,8-dihydro-8-oxoguanine are potent sources of replication errors in vivo. Biochemistry (2003) 1.92
Perfused multiwell plate for 3D liver tissue engineering. Lab Chip (2009) 1.88
A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol Bioeng (2002) 1.87
Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue. AIDS Res Hum Retroviruses (2013) 1.76
Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem (2010) 1.71
Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci U S A (2012) 1.67
Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells (2005) 1.66
The rational design of nitric oxide selectivity in single-walled carbon nanotube near-infrared fluorescence sensors for biological detection. Nat Chem (2009) 1.64
Transport-mediated angiogenesis in 3D epithelial coculture. FASEB J (2009) 1.58
Integration of continuous-flow accelerator mass spectrometry with chromatography and mass-selective detection. Anal Chem (2008) 1.57
Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation. Carcinogenesis (2007) 1.55
A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55
Validated assays for human cytochrome P450 activities. Drug Metab Dispos (2004) 1.52
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity. Toxicol Appl Pharmacol (2009) 1.49
Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo. Biochemistry (2002) 1.48
A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab (2005) 1.47
Global phosphoproteome of HT-29 human colon adenocarcinoma cells. J Proteome Res (2005) 1.46
A three-dimensional osteochondral composite scaffold for articular cartilage repair. Biomaterials (2002) 1.46
Managing the challenge of chemically reactive metabolites in drug development. Nat Rev Drug Discov (2011) 1.45
The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model. Drug Metab Dispos (2004) 1.43
What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs. Drug Metab Rev (2007) 1.42
Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ Health Perspect (2014) 1.41
Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther (2010) 1.39
Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes. FASEB J (2007) 1.35
Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development. J Cell Biol (2007) 1.35
Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine. Drug Metab Dispos (2003) 1.34
An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-alpha. Hepatology (2008) 1.30
Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6. J Clin Pharmacol (2006) 1.27
Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions. Curr Drug Metab (2007) 1.22
Biotransformation reactions of five-membered aromatic heterocyclic rings. Chem Res Toxicol (2002) 1.22
Ziprasidone metabolism, aldehyde oxidase, and clinical implications. J Clin Psychopharmacol (2003) 1.21
PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury. Proc Natl Acad Sci U S A (2010) 1.21
Arylamine exposures and bladder cancer risk. Mutat Res (2002) 1.20
Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities. Integr Biol (Camb) (2010) 1.20
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. Clin Pharmacokinet (2010) 1.19
Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide (2005) 1.19
Mechanical injury and cytokines cause loss of cartilage integrity and upregulate proteins associated with catabolism, immunity, inflammation, and repair. Mol Cell Proteomics (2009) 1.19
An interface for direct analysis of (14)c in nonvolatile samples by accelerator mass spectrometry. Anal Chem (2004) 1.18
Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor. Tissue Eng (2002) 1.16
The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the pharmaceutical research and manufacturers of America. Drug Metab Dispos (2009) 1.16
Examination of 209 drugs for inhibition of cytochrome P450 2C8. J Clin Pharmacol (2005) 1.15
S-Nitrosation regulates the activation of endogenous procaspase-9 in HT-29 human colon carcinoma cells. J Biol Chem (2003) 1.15
Simulations of cell-surface integrin binding to nanoscale-clustered adhesion ligands. Biophys J (2002) 1.15
Selective inhibition of human cytochrome P4502C8 by montelukast. Drug Metab Dispos (2004) 1.15
Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. PLoS Negl Trop Dis (2012) 1.14
Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst (2004) 1.14
Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment. Chem Res Toxicol (2009) 1.14
Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J Virol (2011) 1.13
Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interaction. Drug Metab Dispos (2009) 1.13
In vitro models for liver toxicity testing. Toxicol Res (Camb) (2012) 1.13
Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells. Stem Cells (2009) 1.11
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imaging. Cancer (2012) 1.11
Gene delivery properties of end-modified poly(beta-amino ester)s. Bioconjug Chem (2007) 1.11
Physicochemical determinants of human renal clearance. J Med Chem (2009) 1.11
Increase of reaction rate and sensitivity of low-abundance enzyme assay using micro/nanofluidic preconcentration chip. Anal Chem (2008) 1.11
In vitro-in vivo extrapolation of CYP2D6 inactivation by paroxetine: prediction of nonstationary pharmacokinetics and drug interaction magnitude. Drug Metab Dispos (2005) 1.10
Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.09
Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: implications for relating in vitro inhibition data to in vivo drug interactions. Drug Metab Dispos (2003) 1.08
Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV). Proc Natl Acad Sci U S A (2011) 1.08
An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential. Circulation (2013) 1.06
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem (2010) 1.05
Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes. Drug Metab Dispos (2010) 1.05
Marrow-derived stem cell motility in 3D synthetic scaffold is governed by geometry along with adhesivity and stiffness. Biotechnol Bioeng (2011) 1.05
Cytokine-associated drug toxicity in human hepatocytes is associated with signaling network dysregulation. Mol Biosyst (2010) 1.04
Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res (2007) 1.04
Adenoviral vector saturates Akt pro-survival signaling and blocks insulin-mediated rescue of tumor necrosis-factor-induced apoptosis. J Cell Sci (2006) 1.04
Spiroiminodihydantoin and guanidinohydantoin are the dominant products of 8-oxoguanosine oxidation at low fluxes of peroxynitrite: mechanistic studies with 18O. Chem Res Toxicol (2004) 1.04
Quantitation of four guanine oxidation products from reaction of DNA with varying doses of peroxynitrite. Chem Res Toxicol (2005) 1.04
Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation. Chem Res Toxicol (2013) 1.04
ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proc Natl Acad Sci U S A (2013) 1.02
Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. J Cell Physiol (2009) 1.02
Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study. J Acquir Immune Defic Syndr (2012) 1.01
Covalent adducts arising from the decomposition products of lipid hydroperoxides in the presence of cytochrome c. Chem Res Toxicol (2007) 1.01
Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks. J Med Chem (2012) 1.01
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors. J Med Chem (2014) 1.01
Clonal expansion of adult rat hepatic stem cell lines by suppression of asymmetric cell kinetics (SACK). Biotechnol Bioeng (2003) 1.01
Site-specific and redox-controlled S-nitrosation of thioredoxin. Proc Natl Acad Sci U S A (2011) 1.01
Interplay between PEO tether length and ligand spacing governs cell spreading on RGD-modified PMMA-g-PEO comb copolymers. Biomacromolecules (2007) 1.00
Analysis of nitrated proteins by nitrotyrosine-specific affinity probes and mass spectrometry. Anal Biochem (2003) 0.99
Autocrine-controlled formation and function of tissue-like aggregates by primary hepatocytes in micropatterned hydrogel arrays. Tissue Eng Part A (2011) 0.99
Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS Negl Trop Dis (2013) 0.99
Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation. Sci Transl Med (2014) 0.99
Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients. Carcinogenesis (2006) 0.98
Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells. Stem Cell Rev (2015) 0.98
A comparison of 2-phenyl-2-(1-piperidinyl)propane (ppp), 1,1',1''-phosphinothioylidynetrisaziridine (thioTEPA), clopidogrel, and ticlopidine as selective inactivators of human cytochrome P450 2B6. Drug Metab Dispos (2007) 0.98
Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs. Drug Metab Dispos (2011) 0.97
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A (2013) 0.97
Characterization of testosterone 11 beta-hydroxylation catalyzed by human liver microsomal cytochromes P450. Drug Metab Dispos (2005) 0.97
Chain Conformations at the Surface of a Polydisperse Amphiphilic Comb Copolymer Film. Macromolecules (2006) 0.96
Mechanism-based triarylphosphine-ester probes for capture of endogenous RSNOs. J Am Chem Soc (2013) 0.96
Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors. Drug Metab Dispos (2012) 0.95